All articles tagged with #early diagnosis
Health experts say some language changes are normal with ageing (slower speech, occasional word-finding pauses), but dementia more typically causes loss of words and meanings, vaguer wording, and reduced coherence years before symptoms. There is no single diagnostic test yet; however, advances in language-analysis tools and apps may help flag risk earlier to enable timely intervention.
KOMO News anchor Kelly Koopmans shares her experience getting her first screening mammogram at Seattle’s Swedish Breast Imaging Center after turning 40, highlighting that about 1 in 8 women will develop breast cancer and that mammograms can detect cancer up to two years before symptoms. The 10-minute exam involves four images and may require follow-up; most recalls are not cancer. Her results were negative, and doctors emphasize annual screening for average-risk individuals to catch issues early, underscoring the importance of being proactive about health.
A study of 18 young adults with major depressive disorder found brain and blood cells produce more energy at rest but have a reduced ability to ramp up energy under stress, suggesting a cellular energy imbalance may drive fatigue and low motivation and could aid earlier diagnosis and personalized therapies.
The government unveiled a 10-year cancer strategy to lift five-year survival to 75% by 2035, focusing on earlier diagnosis and faster treatment, including an 85% 62-day referral-to-treatment target by 2029 (up from about 70%), 9.5 million more tests and scans by 2029, expanded screening (bowel and ex-smoker lung), more precision robotic surgery, expanded genetic testing for targeted therapies, and every patient getting a named local care lead with tailored support. Achieving this will require substantial staff recruitment amid current shortages in radiology and clinical oncology, and critics say stronger emphasis on prevention is also needed. Current five-year survival was around 60% in 2022, and the UK lags behind peers on several cancers.
A two-year-old girl in Paisley was diagnosed with Kawasaki disease 10 days after fever began; early treatment with IVIG helped avert potential heart damage, and her family backs awareness efforts like the Light a Landmark campaign to help parents spot signs.
A 75th American Cancer Society Cancer Statistics report shows the U.S. five-year cancer survival rate has risen to about 70% (7‑in‑10) thanks to earlier detection and new treatments like immune checkpoint therapy and CAR‑T cell therapy. Survival has improved across cancers (breast 92%, melanoma 95%, prostate 98%), with leukemia and non‑Hodgkin lymphoma up ~20% and 18% and pancreatic and liver cancers also rising (to 13% and 22%). Myeloma and lung cancer survival have climbed to 62% and 15–28%, while late-stage survival now averages 35% (up from 17%). The death rate has fallen about 34% since 1991, saving roughly 4.8 million lives by 2023 — achievements driven by diagnosis, screening, and innovative therapies rather than a cure.
An international Bio-Hermes-002 trial spanning the UK, US, and Canada is testing a finger-prick blood test that looks for three Alzheimer’s biomarkers to diagnose the disease noninvasively. About 883–1,000 participants aged 60+ are being enrolled to compare the test against standard invasive diagnostics, with researchers and NHS experts stressing that earlier, accurate diagnosis is crucial as new treatments become available.
Scientists at Brown University have identified specific patterns in brain electrical activity, particularly in the beta frequency band, that can predict the development of Alzheimer's disease up to two and a half years before diagnosis, using a novel analytical approach called the Spectral Events Toolbox applied to magnetoencephalography data.
A promising experimental drug called NU-9 has shown potential in preventing Alzheimer's disease in mice by targeting toxic amyloid-β protein subtypes early in the disease process, with future human trials and early diagnostic tests on the horizon.
Scientists at Northwestern University discovered a novel compound, NU-9, that can target a previously unknown subtype of brain protein associated with early Alzheimer's disease in mice, potentially allowing for preventative treatment similar to managing high cholesterol. The compound reduces toxic proteins and inflammation, paving the way for future research on its effectiveness in later stages and its potential to control the disease before symptoms appear.
Scientists at Northwestern University discovered a novel compound, NU-9, that can target a previously unknown brain protein subtype associated with early Alzheimer's disease in mice, potentially allowing for preventative treatment similar to managing high cholesterol. The compound reduces toxic protein accumulation and brain inflammation, paving the way for future research into its effectiveness in later disease stages and its potential to control Alzheimer's before symptoms appear.
New blood tests capable of detecting multiple cancers simultaneously show promise for earlier diagnosis and improved cancer care, but currently face challenges such as high false-positive rates, lack of standardization, and integration into clinical practice. Experts believe these tests will improve over time and could revolutionize cancer diagnostics, though more research and validation are needed.
King Charles III publicly shared his cancer diagnosis and treatment journey, emphasizing the importance of early detection and screening programs, which has inspired increased public interest and awareness about cancer prevention and treatment in the UK.
Chronic snoring can be a warning sign of Obstructive Sleep Apnea (OSA), a condition linked to serious health risks like high blood pressure, stroke, and heart failure. Recognizing symptoms such as loud snoring, breathing pauses, daytime fatigue, and morning headaches is crucial for early diagnosis and intervention, which can significantly reduce long-term health complications.
Chronic kidney disease has become the ninth leading cause of death worldwide, with cases nearly doubling from 1990 to 2023, driven by risk factors like high blood sugar, blood pressure, and BMI. Most cases are in early stages but often go undiagnosed, emphasizing the need for increased testing and access to treatment to prevent progression to dialysis or transplantation. The disease's rising prevalence highlights its importance as a major public health concern.